Hematoporphyrin derivative photoradiation therapy in managing nevoid basal-cell carcinoma syndrome. A preliminary report

David Tse, R. C. Kersten, R. L. Anderson

Research output: Contribution to journalArticle

47 Citations (Scopus)

Abstract

Hematoporphyrin derivative (HpD) is a photodynamically active dye that is preferentially retained by malignant tissues and initiates a cytotoxic reaction when exposed to red light. Normal tissues adjacent to a tumor retain HpD to a lesser degree and are thus spared damage from the light-induced reaction. We describe the treatment of 40 basal-cell carcinomas in three patients with nevoid basal-cell carcinoma syndrome. All treated lesions showed disappearance of clinically apparent tumor within four to six weeks, and there was no damage to surrounding skin. Thirty-three lesions (82.5%) showed complete response on biopsy findings, while seven showed residual tumor cells. The recurrence rate was 10.8%, with the follow-up ranging from 12 to 14 months. Tumor response was related to the total light dose delivered and the size and location of the tumor.

Original languageEnglish
Pages (from-to)990-994
Number of pages5
JournalArchives of Ophthalmology
Volume102
Issue number7
StatePublished - Jan 1 1984
Externally publishedYes

Fingerprint

Hematoporphyrin Photoradiation
Hematoporphyrin Derivative
Basal Cell Nevus Syndrome
Phototherapy
Light
Neoplasms
Basal Cell Carcinoma
Residual Neoplasm
Coloring Agents
Biopsy
Recurrence
Skin

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Hematoporphyrin derivative photoradiation therapy in managing nevoid basal-cell carcinoma syndrome. A preliminary report. / Tse, David; Kersten, R. C.; Anderson, R. L.

In: Archives of Ophthalmology, Vol. 102, No. 7, 01.01.1984, p. 990-994.

Research output: Contribution to journalArticle

@article{008010ac11fc4f59baf504cfdfc51c78,
title = "Hematoporphyrin derivative photoradiation therapy in managing nevoid basal-cell carcinoma syndrome. A preliminary report",
abstract = "Hematoporphyrin derivative (HpD) is a photodynamically active dye that is preferentially retained by malignant tissues and initiates a cytotoxic reaction when exposed to red light. Normal tissues adjacent to a tumor retain HpD to a lesser degree and are thus spared damage from the light-induced reaction. We describe the treatment of 40 basal-cell carcinomas in three patients with nevoid basal-cell carcinoma syndrome. All treated lesions showed disappearance of clinically apparent tumor within four to six weeks, and there was no damage to surrounding skin. Thirty-three lesions (82.5{\%}) showed complete response on biopsy findings, while seven showed residual tumor cells. The recurrence rate was 10.8{\%}, with the follow-up ranging from 12 to 14 months. Tumor response was related to the total light dose delivered and the size and location of the tumor.",
author = "David Tse and Kersten, {R. C.} and Anderson, {R. L.}",
year = "1984",
month = "1",
day = "1",
language = "English",
volume = "102",
pages = "990--994",
journal = "JAMA Ophthalmology",
issn = "2168-6165",
publisher = "American Medical Association",
number = "7",

}

TY - JOUR

T1 - Hematoporphyrin derivative photoradiation therapy in managing nevoid basal-cell carcinoma syndrome. A preliminary report

AU - Tse, David

AU - Kersten, R. C.

AU - Anderson, R. L.

PY - 1984/1/1

Y1 - 1984/1/1

N2 - Hematoporphyrin derivative (HpD) is a photodynamically active dye that is preferentially retained by malignant tissues and initiates a cytotoxic reaction when exposed to red light. Normal tissues adjacent to a tumor retain HpD to a lesser degree and are thus spared damage from the light-induced reaction. We describe the treatment of 40 basal-cell carcinomas in three patients with nevoid basal-cell carcinoma syndrome. All treated lesions showed disappearance of clinically apparent tumor within four to six weeks, and there was no damage to surrounding skin. Thirty-three lesions (82.5%) showed complete response on biopsy findings, while seven showed residual tumor cells. The recurrence rate was 10.8%, with the follow-up ranging from 12 to 14 months. Tumor response was related to the total light dose delivered and the size and location of the tumor.

AB - Hematoporphyrin derivative (HpD) is a photodynamically active dye that is preferentially retained by malignant tissues and initiates a cytotoxic reaction when exposed to red light. Normal tissues adjacent to a tumor retain HpD to a lesser degree and are thus spared damage from the light-induced reaction. We describe the treatment of 40 basal-cell carcinomas in three patients with nevoid basal-cell carcinoma syndrome. All treated lesions showed disappearance of clinically apparent tumor within four to six weeks, and there was no damage to surrounding skin. Thirty-three lesions (82.5%) showed complete response on biopsy findings, while seven showed residual tumor cells. The recurrence rate was 10.8%, with the follow-up ranging from 12 to 14 months. Tumor response was related to the total light dose delivered and the size and location of the tumor.

UR - http://www.scopus.com/inward/record.url?scp=0021253282&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021253282&partnerID=8YFLogxK

M3 - Article

C2 - 6234868

AN - SCOPUS:0021253282

VL - 102

SP - 990

EP - 994

JO - JAMA Ophthalmology

JF - JAMA Ophthalmology

SN - 2168-6165

IS - 7

ER -